FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to pulmonology, and can be used for therapy of contusion syndrome of mediastinal organs and prevention of ventilator-associated pneumonia. For this purpose drug mixture is introduced subcutaneously retrosternal, consisting of 5,000 units of heparin, 100 mg of lidocaine, 8 mg of dexamethasone, 2 g ceftriaxone, 1 time a day for 5 days.
EFFECT: invention provides reduced length of treatment reduced probability of ventilator-associated pneumonia in patients in comparison with close analogue.
1 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING ACUTE LUNG INJURY IN THE SURGICAL TREATMENT OF NON-SMALL CELL LUNG CANCER COMPLICATED BY AN INFLAMMATORY PROCESS | 2022 |
|
RU2801089C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LUNG EDEMA | 1995 |
|
RU2116799C1 |
| METHOD FOR TREATMENT OF PNEUMONIA IN NEWBORNS | 2003 |
|
RU2239450C1 |
| METHOD OF REGIONAL LYMPH STIMULATION AND ANESTHETIZATION IN PATIENTS WITH SCARY STRICTURE OF ESOPHAGUS AFTER CHEMICAL BURN | 2004 |
|
RU2263515C1 |
| METHOD FOR ADMINISTERING POSTOPERATIVE INTENSIVE CARE OF GENERALIZED PERITONITIS PATIENTS | 2003 |
|
RU2228193C1 |
| METHOD FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT | 2015 |
|
RU2611414C1 |
| PREVENTIVE METHOD OF SUPPURATIVE-SEPTIC COMPLICATIONS CASUED BY SEVERE COMBINED INJURY | 2006 |
|
RU2326687C1 |
| METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
| DIAGNOSTIC TECHNIQUE FOR VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS IN NEWBORNS SUPPORTED BY ARTIFICIAL PULMONARY VENTILATION | 2009 |
|
RU2408016C1 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
